Jacqualyn Fouse - Chief Executive Officer, Agios Pharmaceuticals, Inc

As of April 12, 2022


Jacqualyn Fouse Net Worth

  • Net worth is estimated to be at least $21.31M
  • Owns at least 41,722 units of Agios Pharmaceuticals, Inc stock
  • Sold an estimated value of $363.01K in the last 4 years at Agios Pharmaceuticals, Inc

Jacqualyn Fouse Compensation at Agios Pharmaceuticals, Inc in 2020

  • Earned a $746,750 salary
  • Rewarded $1,751,340 in stock value and options
  • Received a total compensation of $7,611,975

Jacqualyn Fouse Trading

  • Largest purchase of shares was 40,322 units , worth over $1.25M on November 15, 2019
  • In total has made about 11 transactions over 4 years
  • Usually trades in February, with the busiest year in 2019 and 2022
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jacqualyn Fouse Mailing Address

  • Mailing address is C/o Dick'S Sporting Goods 345 Court Street Coraopolis PA 15108 PA

Agios Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Jacqualyn A. Fouse, Ph.D. 2020 $746,750 - $1,751,340 $4,593,651 $509,657 $10,577 $7,611,975
Jacqualyn A. Fouse, Ph.D. 2019 $664,583 - $2,538,474 $12,875,608 $424,125 $105,204 $16,607,994
Jacqualyn A. Fouse, Ph.D. 2018 - - - - - - -
Jonathan Biller 2020 $500,000 - - - $258,750 $10,578 $769,328
Jonathan Biller 2019 $39,583 $110,000 $1,008,334 $2,025,036 - $936 $3,183,889
Jonathan Biller 2017 - - - - - - -
Christopher Bowden, M.D. 2020 $515,007 - $618,120 $1,508,875 $243,341 $9,203 $2,894,546
Christopher Bowden, M.D. 2019 $490,539 - $915,590 $1,609,989 $198,668 $12,422 $3,227,208
Christopher Bowden, M.D. 2018 $467,141 - $641,025 $1,746,517 $262,767 $11,280 $3,128,730
Bruce Car, Ph.D. 2020 $494,318 - $833,301 $1,499,943 $236,250 $164,231 $3,228,043
Bruce Car, Ph.D. 2019 - - - - - - -
Bruce Car, Ph.D. 2018 - - - - - - -
Andrew Hirsch 2020 $361,234 - $618,120 $1,508,875 - $397,893 $2,886,122
Andrew Hirsch 2019 $500,476 - $1,923,145 $1,609,989 $202,693 $12,528 $4,248,831
Andrew Hirsch 2018 $471,329 - $641,025 $1,746,517 $265,123 $12,864 $3,136,858
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1439222/000119312521110205/d71514ddef14a.htm

Agios Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 108 units sold on March 1, 2022 by Theodore James JrWashburn worth over $3.24K
  • In the last 9 years, insiders at Agios Pharmaceuticals, Inc sold an estimated value of $169.32M and bought an estimated value of $171.9M
  • The most active traders are Scott Biller, Chief Scientific Officer,  David Schenkein, Director,  and John Duncan Higgons, Chief Operating Officer
  • Insider trading is most common in February, with the busiest year in 2014

AGIOS PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1